1 Department of Hematology, University Hospital of Reims and UFR Médecine, Reims, France.
2 Department of Research and Public Health, University Hospital of Reims, and UR 3797, Vieillissement, Fragilité (VieFra), Faculty of Medicine, University of Reims Champagne-Ardenne, Reims, France.
3 Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
4 Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, Arizona, USA.
5 University College London Hospitals (UCLH) Centre for Waldenström Macroglobulinemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, UK.
6 Department of Hematology, Institut de Cancérologie Strasbourg Europe (ICANS), Strasbourg, France.
7 Sorbonne Université, Hematology, Pitié-Salpêtrière Hospital, Paris, France.
8 Department of Hematology, University Hospital of Salamanca, CIBERONC and Research Biomedical Institute of Salamanca (IBSAL), Salamanca, Spain.
9 Department of Hematology, Amsterdam University Medical Center (UMC), University of Amsterdam, Amsterdam, The Netherlands.
10 Department of Hematology, Léon Bérard Center, Lyon, France.
11 Department of Hematology, ACT Pathology, Canberra Hospital, Canberra, Australia.
12 College of Health and Medicine, Australian National University, Canberra, Australia.
13 Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece.
14 Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
15 Department of Hematology, University Hospital of Amiens, Amiens, France.